Skip to content
10-K/A

Annual Report

BIOXYTRAN, INC. BIXT

0001493152-25-001889

← back to feed
Filed
Jan 13, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jan 13, 2025 88.13M sh
Shares Diluted restated FY 2023 · Dec 31, 2023 133.97M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 112.71M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$775.38K
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$1.8M
Current Liabilities restated FY 2023 · Dec 31, 2023 $3.24M
Current Liabilities restated FY 2023 · Dec 31, 2022 $3.67M
Total Liabilities restated FY 2023 · Dec 31, 2023 $3.24M
Total Liabilities restated FY 2023 · Dec 31, 2022 $3.67M
Current Assets FY 2023 · Dec 31, 2023 $26.09K
Current Assets FY 2023 · Dec 31, 2022 $295.4K
Total Assets restated FY 2023 · Dec 31, 2023 $139.38K
Total Assets FY 2023 · Dec 31, 2022 $370.94K
Eps Diluted FY 2023 · Dec 31, 2023 −$0.03
Eps Diluted FY 2023 · Dec 31, 2022 −$0.02
Eps Basic FY 2023 · Dec 31, 2023 −$0.03
Eps Basic FY 2023 · Dec 31, 2022 −$0.02
Rd Expense FY 2023 · Dec 31, 2023 $1.15M
Rd Expense restated FY 2023 · Dec 31, 2022 $1.28M
Net Income restated FY 2023 · Dec 31, 2023 −$4.47M
Net Income restated FY 2023 · Dec 31, 2022 −$2.47M
Operating Income restated FY 2023 · Dec 31, 2023 −$3.8M
Operating Income restated FY 2023 · Dec 31, 2022 −$2.44M